IL166548A0 - Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide - Google Patents

Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide

Info

Publication number
IL166548A0
IL166548A0 IL16654805A IL16654805A IL166548A0 IL 166548 A0 IL166548 A0 IL 166548A0 IL 16654805 A IL16654805 A IL 16654805A IL 16654805 A IL16654805 A IL 16654805A IL 166548 A0 IL166548 A0 IL 166548A0
Authority
IL
Israel
Prior art keywords
octylü
carbampyl
acidä4
fluorobenzyl
quinoxaline
Prior art date
Application number
IL16654805A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL166548A0 publication Critical patent/IL166548A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16654805A 2002-08-12 2005-01-27 Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide IL166548A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40321602P 2002-08-12 2002-08-12
PCT/IB2003/003464 WO2004014875A1 (en) 2002-08-12 2003-07-31 Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide

Publications (1)

Publication Number Publication Date
IL166548A0 true IL166548A0 (en) 2006-01-15

Family

ID=31715961

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16654805A IL166548A0 (en) 2002-08-12 2005-01-27 Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide

Country Status (22)

Country Link
US (1) US20040072834A1 (xx)
EP (1) EP1539715A1 (xx)
JP (1) JP2005538130A (xx)
AP (1) AP2005003226A0 (xx)
AR (1) AR040839A1 (xx)
AU (1) AU2003250450A1 (xx)
BR (1) BR0313378A (xx)
CA (1) CA2494776A1 (xx)
EC (1) ECSP055588A (xx)
GT (1) GT200300169A (xx)
IL (1) IL166548A0 (xx)
IS (1) IS7674A (xx)
MX (1) MXPA05001781A (xx)
NO (1) NO20050540L (xx)
OA (1) OA12894A (xx)
PA (1) PA8580401A1 (xx)
PE (1) PE20040866A1 (xx)
TN (1) TNSN05035A1 (xx)
TW (1) TW200407316A (xx)
UY (1) UY27928A1 (xx)
WO (1) WO2004014875A1 (xx)
ZA (1) ZA200500768B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5731538B2 (ja) 2009-12-23 2015-06-10 アイアンウッド ファーマシューティカルズ インコーポレイテッド Ｃｒｔｈ２モジュレーター
US20130216552A1 (en) 2010-07-12 2013-08-22 Ironwood Pharmaceuticals, Inc. Crth2 modulators
WO2012009134A1 (en) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Crth2 modulators
CN102276539B (zh) * 2011-06-29 2013-08-14 赵雪梅 一种具有抑菌作用的化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE640616A (xx) * 1962-12-19
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
KR100447553B1 (ko) * 1997-02-26 2004-09-08 화이자 인코포레이티드 헤테로아릴-헥사노산 아미드 유도체, 그의 제조 방법 및 ｍｉｐ-1 알파의 ｃｃｒ1 수용체로의 결합에 대한 선택적 저해제로서의 용도
CN1177834C (zh) * 1998-02-05 2004-12-01 辉瑞产品公司 二羟基己酸衍生物

Also Published As

Publication number Publication date
NO20050540L (no) 2005-03-10
UY27928A1 (es) 2004-03-31
US20040072834A1 (en) 2004-04-15
TNSN05035A1 (fr) 2007-05-14
AR040839A1 (es) 2005-04-20
BR0313378A (pt) 2005-07-12
ECSP055588A (es) 2005-04-18
MXPA05001781A (es) 2005-04-25
EP1539715A1 (en) 2005-06-15
OA12894A (en) 2006-10-13
PE20040866A1 (es) 2004-11-26
CA2494776A1 (en) 2004-02-19
ZA200500768B (en) 2006-07-26
WO2004014875A1 (en) 2004-02-19
AP2005003226A0 (en) 2005-03-31
TW200407316A (en) 2004-05-16
IS7674A (is) 2005-01-27
AU2003250450A1 (en) 2004-02-25
GT200300169A (es) 2004-05-12
PA8580401A1 (es) 2004-02-16
JP2005538130A (ja) 2005-12-15

Similar Documents

Publication Publication Date Title
AU2003241561A1 (en) Pyrazolo-pyrimidine aniline compounds
AU2003247483A1 (en) Methods for treatment of acute lymphocytic leukemia
GB2389161B (en) Composite wave ring spring
EP1575980A4 (en) RNA INTERFERENCE
AU2003295539A8 (en) Allele-targeted rna interference
AU2003282548A1 (en) Nano-chem-fet based biosensors
AU2003225095A1 (en) Parallel sizing, dosing and transfer assembly and method of use
ZA200501624B (en) Flat lamp, production method thereof and application of same.
IL166548A0 (en) Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide
AU2003222120A1 (en) Oxon process
AU148618S (en) Wok
IL166450A0 (en) Drug discovery method
TWI367754B (en) New carboxamide compound
AU2003252714A1 (en) Filter element, filter and method of using and method of cleaning the same
EP1483233A4 (en) SUBSTITUTED TETRAHYDROISOQUINOLEINE COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF
EG23393A (en) Production of olefins.
EG23381A (en) Production of olefins.
AU2003287844A1 (en) Novel crystalline forms of entacapone, and production thereof
AU2003206438A1 (en) Assembly of structural elements, structural element and use of such an assembly
EP1517879A4 (en) AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
AU2003214836A1 (en) Combined gemstone
GB2392746B (en) Comparison of molecules using field points
GB2389272B (en) SIM Configuration
GB0220463D0 (en) Networks